Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Azithromycin (Zithromax, the "Z-Pack") treats specific bacterial infections, not viral ones. Here's what the evidence, dosing, and timeline actually show.
Azithromycin has fewer drug interactions than most macrolides, but heart rhythm effects and a handful of specific combinations still deserve real attention.
Azithromycin remains an effective, well-studied treatment for chlamydia, though guidance has shifted toward doxycycline as the preferred first-line option in most non-pregnant adults.
Azithromycin is the antibiotic backbone of global trachoma control, replacing weeks of eye ointment with a single oral dose backed by decades of trial data.
How a single antibiotic, distributed by the hundreds of millions of doses, has helped push a leading cause of preventable blindness toward elimination.
The classic Z-Pack taper isn't arbitrary. It reflects decades of pharmacokinetic research into how azithromycin behaves in the body.
Azithromycin blocks bacteria from building proteins by jamming a tunnel deep inside their ribosomes. Here is the real molecular story, and what remains uncertain.
Azithromycin's unusual chemistry allows short courses to work, but that same chemistry raises real questions about resistance and cardiac safety worth understanding.